Search Legislation

The Misuse of Drugs Act 1971 (Amendment) Order 2017

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Statutory Instruments

2017 No. 634

Dangerous Drugs

The Misuse of Drugs Act 1971 (Amendment) Order 2017

Made

3rd May 2017

Coming into force in accordance with article 1

At the Court at Buckingham Palace, the 3rd day of May 2017

Present,

The Queen’s Most Excellent Majesty in Council

In accordance with section 2(5) of the Misuse of Drugs Act 1971(1) a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.

Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:

Citation and commencement

1.  This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2017 and comes into force on the twenty-eighth day after the day on which it is made.

Amendments to the Misuse of Drugs Act 1971

2.  The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.

3.  In paragraph 1(a) of Part 1 (which specifies the drugs which are subject to control under that Act as Class A drugs), after “3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921).” insert—

3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700)..

4.  In paragraph 1(a) of Part 2 (which specifies the drugs which are subject to control under that Act as Class B drugs)—

(a)after “Amphetamine.” insert—

N-Benzyl-ethylphenidate.;

(b)after “Ethylmorphine (3-ethylmorphine).” insert—

Ethylnaphthidate.

Ethylphenidate.;

(c)after “Glutethimide.” insert—

Isopropylphenidate (IPP or IPPD).;

(d)after “Methcathinone.” insert—

Methylmorphenate.

Methylnaphthidate (HDMP-28).;

(e)after “Propiram.” insert—

Propylphenidate.;

(f)after “Zipeprol.” insert—

3,4-Dichloroethylphenidate.

3,4-Dichloromethylphenidate (3,4-DCMP).;

(g)after “2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol” insert—

4-Fluoroethylphenidate.

4-Fluoromethylphenidate.

4-Methylmethylphenidate..

5.  In paragraph 1(a) of Part 3 (which specifies the drugs which are subject to control under that Act as Class C drugs)—

(a)before “Alprazolam” insert—

Adinazolam (1-(8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine).;

(b)after “Bromazepam” insert—

Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).;

(c)after “Cathinone” insert—

4’-Chlorodiazepam (7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one).;

(d)after “Clonazepam” insert—

Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine).;

(e)after “Delorazepam” insert—

Deschloroetizolam (2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine).;

(f)after “Diazepam” insert—

Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one).;

(g)after “Ethyl loflazepate” insert—

Etizolam.;

(h)after “Fenproporex” insert—

Flubromazepam (7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one).

Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine).;

(i)after “Flurazepam” insert—

Fonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).;

(j)after “4-Hydroxy-n-butyric acid” insert—

3-Hydroxyphenazepam (7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one).;

(k)after “Mazindol” insert—

Meclonazepam (5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one).;

(l)after “Methyprylone” insert—

Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]  diazepine).;

(m)after “Midazolam” insert—

Nifoxipam (5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-  one).;

(n)after “Nitrazepam” insert—

Nitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).;

(o)after “Prazepam” insert—

Pyrazolam (8-Bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)..

Richard Tilbrook

Clerk of the Privy Council

EXPLANATORY NOTE

(This note is not part of the Order)

This Order brings certain drugs under the control of the Misuse of Drugs Act 1971 (‘the Act’). Article 3 of this Order brings a synthetic opioid known as U-47,700 under permanent control as a Class A drug under the Act. Article 4 brings several methylphenidate related materials under permanent control as Class B drugs. A number of these methylphenidate related materials were specified under section 2A of the Act as drugs subject to temporary control by virtue of the Misuse of Drugs Act 1971 (Temporary Class Drug) Order 2016 (S.I. 2016/650) and cease to be subject to such temporary control on the coming into force of this Order in accordance with section 2A(6)(b) of the Act. Article 5 brings several designer benzodiazepines under permanent control as Class C drugs.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources